PDS BIOTECHNOLOGY CORPORATION
PDS Biotechnology Corporation is a biopharmaceutical company. It develops immunotherapies for cancer and other infectious diseases. It develops products to prevent and treat cervical, ovarian, melanoma, leukemia, pancreatic, oral, multiple myeloma, anal, vulvar, and penile cancers. The company offers PDS0101, a treatment for HPV-related cancers; PDS0102, a pandemic influenza vaccine; and PDS0103, a line of immunotherapy products for non-viral cancers. PDS Biotechnology Corporation was founded in 2005 and is headquartered in North Brunswick, New Jersey.
PDS BIOTECHNOLOGY CORPORATION
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2005-01-01
Address:
North Brunswick, New Jersey, United States
Country:
United States
Website Url:
http://www.pdsbiotech.com
Total Employee:
1+
Status:
Active
Contact:
5132211891
Total Funding:
57.04 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Horizon Technology Finance
Horizon Technology Finance investment in Post-IPO Debt - PDS Biotechnology Corporation
Key Employee Changes
Official Site Inspections
http://www.pdsbiotech.com Semrush global rank: 2.12 M Semrush visits lastest month: 9.58 K
- Host name: host2.sandmanmedia.com
- IP address: 69.16.221.82
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
More informations about "PDS Biotechnology Corporation"
PDS Biotech - About
PDS Biotech is committed to developing novel and effective therapies based on the Versamune® platform to save and improve the lives of cancer patients worldwide. We are also committed to …See details»
PDS Biotech - Investor Relations
Oct 22, 2024 PDS Biotech is committed to developing novel and effective therapies based on the Versamune® platform to save and improve the lives of cancer patients worldwide. We are …See details»
CORPORATE OVERVIEW - PDS Biotech
Nasdaq: PDSB Versamune® is designed to induce a robust and targeted anti-tumor response in vivo when administered with a tumor-associated antigen 5 References: Gandhapudi SK, et al. …See details»
PDS Biotechnology - Overview, News & Similar companies
Jan 22, 2024 PDS Biotechnology contact info: Phone number: (800) 208-3343 Website: www.pdsbiotech.com What does PDS Biotechnology do? PDS Biotechnology Corporation is a …See details»
PDS Biotechnology: Contact Details and Business Profile
PDS Biotech is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies based on the Versamune® platform, a T-cell activating …See details»
PDS BIOTECHNOLOGY CORPORATION | VentureRadar
Website: http://www.pdsbiotech.com/ Develops clinical-stage immunotherapies and infectious disease vaccines using proprietary Versamune® T-cell activating technology ...See details»
PDS Biotechnology Corporation - Crunchbase …
PDS Biotechnology Corporation is a biopharmaceutical company. It develops immunotherapies for cancer and other infectious diseases. It develops products to prevent and treat cervical, ovarian, melanoma, leukemia, pancreatic, oral, …See details»
PDS Biotechnology - LinkedIn
PDS Biotech is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies based on the Versamune® platform, a T-cell activating technology, designed ...See details»
PDS Biotechnology Corp.
For more information, please visit www.pdsbiotech.com. Forward Looking StatementsThis communication contains forward-looking statements (including within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended, and Section 27A of the United States Securities Act of 1933, as amended) concerning PDS Biotechnology …See details»
PDS Biotechnology Corporation - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for PDS Biotechnology Corporation of Princeton, NJ. Get the latest business insights from Dun & Bradstreet.See details»
PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
PRINCETON, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage immunotherapy company …See details»
PDS Biotech - Leadership Team
Conn subsequently became a Director in the Process Development department at Covance Biotechnology Services Inc., a contract research and development and drug manufacturing organization, where he supervised the analytical …See details»
PDS Biotech Announces Exclusive Global License Agreement for ...
Jan 3, 2023 Under the terms of the agreement, PDS Biotech will receive from Merck KGaA, Darmstadt, Germany an exclusive license to M9241. PDS Biotech will assume responsibility …See details»
Company Description - Stock Analysis
4 days ago Ticker Symbol: PDSB: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001472091: CUSIP Number: 70465T107: ISIN …See details»
PDS Biotech Completes $35 Million Financing Agreement Led By …
Aug 24, 2022 Initial tranche of $25 million provides funding in preparation for registrational trial for lead candidate PDS0101Conference call scheduled for Thursday, August 25, 2022 at 8:00 …See details»
PDS Biotechnology Corporation (PDSB) - Stock Analysis
2 days ago Website https://www.pdsbiotech.com. Full Company Profile. Financial Performance. Financial Statements. Analyst Forecast. According to 3 analysts, the average rating for PDSB …See details»
PDS Biotechnology Reports Inducement Grant Under Nasdaq
8 hours ago For more information, please visit www.pdsbiotech.com. Forward Looking Statements. This communication contains forward-looking statements (including within the meaning of Section 21E of the United ...See details»
PDS Biotech Completes $35 Million Financing Agreement Led
Aug 24, 2022 Email: [email protected]. Nicole Jones CG Capital Phone: +1 (404) 736-3838 Email: [email protected]. Tags Biotechnology ONCOLOGY versamune. Related …See details»
PDS Biotech Announces Interim Data Demonstrates 12-Month …
May 25, 2023 Interim data being presented at ASCO 2023 Annual Meeting Demonstrated median progression-free survival (PFS) of 10.4 months Demonstrated 12-month overall …See details»